No Detail Found!

Inhibitory activities of new series of 4, 5-diaryl thiadiazoles derivatives on lipopolysaccharide-induced Cox-2 expression.

Author(s)
Seyed Nasser Ostad Department of Toxicology and Pharmacology, Tehran University of Medical Sciences, P.O. Box 14155/645 1, Tehran, Iran
Zahra Haghipour Department of Toxicology and Pharmacology, Tehran University of Medical Sciences, P.O. Box 14155/645 1, Tehran, Iran
Mohammad Hosein Ghahremani Department of Toxicology and Pharmacology, Tehran University of Medical Sciences, P.O. Box 14155/645 1, Tehran, Iran
Mohsen Amini Department of Medicinal Chemistry, Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, P.O. Box 14155/645 1, Tehran, Iran
Leila Karimi Department of Medicinal Chemistry, Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, P.O. Box 14155/645 1, Tehran, Iran
Latifeh Navidpour Department of Medicinal Chemistry, Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, P.O. Box 14155/645 1, Tehran, Iran
Abbas Shafiee Department of Medicinal Chemistry, Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, P.O. Box 14155/645 1, Tehran, Iran
Abstract
Abstract: Recent studies have suggested cyclooxygenase-2 (COX-2) expression as a mechanism involved in carcinogenesis. It has also been suggested that changes in COX-2 expression level can be considered as a possible therapeutic target in tumors. Therefore, it was decided to synthesize a new series of 4, 5-diaryl thiadiazoles (compounds 1-5) as COX-2 inhibitors and evaluate their inhibitory activity on COX-2 expression. The COX-2 expression was induced by lipopolysaccharide (LPS) in bovine aortic endothelial (BAE-1) cells and the protein expression was evaluated by immunocytochemistry (ICC). The inhibitory activity of these compounds has been compared with celecoxib and rofecoxib as selective COX-2 inhibitors and indomethacin as a non-selective COX inhibitor. The cytotoxicity of these compounds was measured in different concentrations (10-3-103µg mL-1 by trypan blue dye exclusion method. The results showed that the cell viability following exposure to 10-2 µg mL-1 of each one of compounds 1-4 was about 90%. Among all tested compounds, compound 4 at 10-2 µg mL-1 showed significant inhibition on COX-2 expression determined by ICC. This effect of compound 4 was comparable to rofecoxib and celecoxib. It is concluded that, the new synthesized compounds and in particular, the compound 4 can be considered for further evaluation as new COX-2 inhibitors.
Publication Details
Page(s) 79-84
DOI DOI not available
Published Journal: International Journal of Pharmacology, Volume: 1, Issue: 1, Year: 2005

Request the full text from PASTIC

0

Citations

0

Downloads

25

Views